Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 21.2% in October

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 13,400 shares, a decline of 21.2% from the October 15th total of 17,000 shares. Based on an average trading volume of 43,500 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Trading of Global X Genomics & Biotechnology ETF

Several institutional investors and hedge funds have recently modified their holdings of GNOM. Sanctuary Advisors LLC purchased a new stake in shares of Global X Genomics & Biotechnology ETF during the second quarter worth about $590,000. One Capital Management LLC grew its holdings in Global X Genomics & Biotechnology ETF by 22.1% during the 2nd quarter. One Capital Management LLC now owns 680,311 shares of the company’s stock valued at $7,102,000 after buying an additional 123,339 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in Global X Genomics & Biotechnology ETF by 10.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 67,712 shares of the company’s stock valued at $707,000 after buying an additional 6,260 shares in the last quarter. Insight Advisors LLC PA lifted its holdings in shares of Global X Genomics & Biotechnology ETF by 59.0% in the second quarter. Insight Advisors LLC PA now owns 21,177 shares of the company’s stock worth $221,000 after buying an additional 7,861 shares in the last quarter. Finally, Centaurus Financial Inc. purchased a new stake in Global X Genomics & Biotechnology ETF in the 2nd quarter worth $146,000. 56.95% of the stock is currently owned by institutional investors.

Global X Genomics & Biotechnology ETF Trading Down 5.4 %

NASDAQ GNOM traded down $0.55 on Friday, reaching $9.65. 81,908 shares of the stock were exchanged, compared to its average volume of 57,130. The firm has a market capitalization of $70.54 million, a PE ratio of -4.12 and a beta of 1.03. Global X Genomics & Biotechnology ETF has a one year low of $9.57 and a one year high of $12.53. The company’s 50-day simple moving average is $10.87 and its two-hundred day simple moving average is $10.87.

About Global X Genomics & Biotechnology ETF

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.